Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> GLAXOSMITHKLINE Latest News

9 HOURS AGO - Zero Hedge

A Must Read - Share

Frontrunning: October 23

Canada PM vows crackdown after capital shocked by fatal attacks (Reuters) Canada Gunman Was Convert to Islam With Criminal Record (BBG) Some U.S. hospitals weigh withholding care to Ebola patients (Reuters) But... Great rotation... Bond funds stock up on Treasuries in prep for market shock (Reuters) Saudis at War With Islamic State Confront Echo of Kingdom’s Past (BBG) EU’s Top ...

Tags: Frontrunning: October 23,  Glaxosmithkline Latest News

14 HOURS AGO - The Independent

A Must Read - Share

GSK to float its HIV cures as a standalone £15bn drugs giant

GlaxoSmithKline is planning to turn its HIV treatments into a standalone company floated on the stock market, where it could be high up in the FTSE 100 index.

Tags: GSK to float its HIV cures as a standalone £15bn drugs giant,  Glaxosmithkline Latest News

20 HOURS AGO - The Independent

A Must Read - Share

Glaxo to float its HIV cures as a standalone £15bn drugs giant

GlaxoSmithKline is planning to turn its HIV treatments into a standalone company floated on the stock market, where it could be high up in the FTSE 100 index.

Tags: Glaxo to float its HIV cures as a standalone £15bn drugs giant,  Glaxosmithkline Latest News

OCT 22, 2014 - BBC

A Must Read - Share

Insurance firms and Glaxo lift FTSE

The London market closes higher boosted by better-than-expected results from drugs giant GlaxoSmithKline and a sharp rise in insurance firm shares.

Tags: Insurance firms and Glaxo lift FTSE,  Glaxosmithkline Latest News

OCT 22, 2014 - TheStreet

A Must Read - Share

J&J Sees 250,000 Ebola Vaccine Doses Ready for Trials in May

NEW BRUNSWICK, N.J. (AP) - Johnson & Johnson awill begin safety testing in early January on a vaccine combination that could protect people from a strain of the deadly Ebola virus. The health care products maker said Wednesday that the vaccine being developed by its Janssen Pharmaceutical Companies protects against an Ebola strain that is "highly similar" to the virus ...

Tags: J&J Sees 250,000 Ebola Vaccine Doses Ready for Trials in May,  Glaxosmithkline Latest News